DONG-A ST

DONG-A ST is primarily a manufacturer (factory).

Enterprise Introduction:

Headquarters: Seoul, South Korea

Industry: Pharmaceutical and Healthcare

DONG-A ST Co., Ltd. is a prominent South Korean pharmaceutical company committed to advancing global health through innovative research, development, and manufacturing of high-quality pharmaceutical products. Established in 2013 as a spin-off from Dong-A Pharmaceutical Co., Ltd., DONG-A ST focuses specifically on the ethical drug (prescription drug) business, along with medical devices and diagnostics.

The company's core business areas encompass:

* Prescription Drugs: Developing and manufacturing a wide range of medications for various therapeutic areas, including cardiovascular, central nervous system (CNS), respiratory, metabolic disorders, anti-infectives, and oncology.

* Medical Devices: Producing advanced medical equipment and solutions.

* Diagnostics: Providing diagnostic products for accurate disease detection and monitoring.

DONG-A ST maintains significant investments in research and development, aiming to discover and commercialize novel treatments for unmet medical needs. It operates its own state-of-the-art manufacturing facilities, ensuring stringent quality control and efficient production of its diverse product portfolio. The company is actively engaged in global partnerships and collaborations to expand its reach and contribute to global healthcare.

Here are some products manufactured or sold by DONG-A ST Co., Ltd. of South Korea:

* **Pharmaceuticals:**

* Motilitone (Digestive motility enhancer)

* Zydena (Erectile dysfunction treatment)

* Suganon (DPP-4 inhibitor for diabetes)

* Gastroenterology drugs

* Cardiovascular drugs

* Pain relievers

* **Medical Devices:**

* Accu-Fine (Insulin pen needle)

* **Diagnostic Reagents:**

* **Others:**

* OTC products (e.g., Bacchus-D energy drink, Panalgesic pain relief products)

* Contract manufacturing services for other pharmaceutical companies.

Please note that this is not an exhaustive list, and their product portfolio may change over time.